Remove 2012 Remove Hospice Remove Palliative nursing
article thumbnail

Ep. 43 - An Insider’s View: An Insider’s View: A Pediatric Nurse Practitioner’s Reflections as a Palliative Care Clinician, Caregiver, and Mother

HPNA podcast

Listen for what the health care teams did well, areas where they could improve, and how administrators can champion hospice and palliative care services to make end of life easier for patients and their families. This led her to also become a board-certified pediatric hospice and palliative nurse in 2009.

article thumbnail

Episode 19 - Palliative Nursing Acute to Post Acute Transitions in Care

HPNA podcast

. Palliative Nursing Acute to Post Acute Transitions in Care: Challenges and Opportunities. Dr. Gentry is a nurse practitioner with the Duke University Palliative Care Consult Service, faculty at the Duke University School of Nursing, and a member of the Duke Hospital Ethics Committee.

professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Developing DIGNISPACE – a dignity therapy-based app protype for young people with life-limiting conditions

Evidence-Based Nursing - BMJ blogs

Dignity Therapy (DT) is a brief psycho-therapeutic intervention that assists individuals with shortened life expectancies to have meaning and purpose (Chochinov, 2012). You can follow Jo on X: @josmith175 Dr Michael Tatterton is a Clinical Associate Professor, University of Bradford and the Clinical Director, Bluebell Wood Children’s Hospice.

2002 92
article thumbnail

Undisclosed Conflicts of Interest by Physicians Creating the CDC Opioid Prescribing Guidelines: Bad Faith or Incompetence?

Pallimed

PROP and Chou petitioned the Food and Drug Administration (FDA) to change opioid labeling in July 2012 (29, 30), but FDA rejected PROP’s call for a maximum daily dose of opioid analgesia of 100 morphine milligram equivalents (MME) based on a lack of supporting data (31). Kollas provided testimony at a 2004 Congressional Hearing on OxyContin.

2016 145
article thumbnail

PROP’s Disproportionate Influence on U.S. Opioid Policy: The Harms of Intended Consequences

Pallimed

PROP Petition to the FDA on Opioid Labeling The Petition is Filed In its first effort to influence national opioid policy, in July 2012, PROP submitted a Petition to the Food and Drug Administration (FDA) calling for a change in labeling of opioid analgesics (8). PROP Petition to FDA, 2012, See [link] 9. August 16, 2012.

2016 98